Nicotinamide adenine dinucleotide (NAD+) repletion attenuates bupivacaine-induced neurotoxicity. | Neurochem Res;38(9): 1880-94, 2013 Sep. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Nicotinamide adenine dinucleotide (NAD+) repletion attenuates bupivacaine-induced neurotoxicity.

Zheng, Ting; Xu, Shi Yuan; Zhou, Shu Qin; Lai, Lu Ying; Li, Le.

Affiliation

Zheng T; Department of Anesthesiology, Zhujiang Hospital, Southern Medical University, 253 Industrial Road, Guangzhou, 510280, Guangdong Province, China.

Neurochem Res ; 38(9): 1880-94, 2013 Sep.

Article in En | MEDLINE | ID: mdl-23817845

Subject(s)

NAD/metabolism; Bupivacaine/pharmacology; Cell Line, Tumor; Flow Cytometry; Humans; Lidocaine/pharmacology; Membrane Potential, Mitochondrial/drug effects; Reactive Oxygen Species/metabolism

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: NAD Limits: Humans Language: En Journal: Neurochem Res Year: 2013 Document type: Article Affiliation country: China

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: NAD Limits: Humans Language: En Journal: Neurochem Res Year: 2013 Document type: Article Affiliation country: China